However, considering that immune populations in gliomas are rare in general (compared with other malignancies) and especially depleted in epigenetically driven gliomas compared to IDH-WT gliomas, single-cell profiling of bulk tumors is generally only able to profile enough cells for a broad characterization. This evidence concerns the gene IDH1 and central nervous system cancer.